Literature DB >> 27734216

Central Aspects of Nausea and Vomiting in GI Disorders.

Prashant Singh1, Braden Kuo2.   

Abstract

OPINION STATEMENT: Nausea and vomiting result from continuous interactions among gastrointestinal, central nervous system, and autonomic nervous system. Despite being closely associated, central pathways of nausea and vomiting appear to be at least partly different and nausea is no longer considered only a penultimate step of vomiting. Although our understanding of central pathways of nausea has improved over the last one decade, it is still very basic. Afferent pathways from gastrointestinal tract via vagus, vestibular system, and chemoreceptor trigger zone project to nucleus tractus solitarius which, in turn, relays the signal to central pattern generator initiating multiple downstream pathways. This central nausea pathway appears to be under constant modulation by autonomic nervous system and cerebral cortex. There is also some evidence that central pathway of chronic nausea is different from that of acute nausea and closely resembles that of neuropathic pain. This improved understanding has modified the way we can approach the treatment of acute and chronic nausea. While conventional therapies such as antiemetics (antiserotoninergic, antihistaminic, antidopaminergic) and prokinetics are commonly used to manage acute nausea, they are not as effective in improving chronic nausea. Recently, neuromodulators such as tricyclic antidepressants, gabapentin, olanzapine, benzodiazepines, and cannabinoids have been shown to have antinausea effect. There is a need to study the utility of these drugs in managing chronic functional nausea. Improving our understanding of central and peripheral circuitry of nausea will allow us to better utilize the currently available drugs and develop new therapeutic options.

Entities:  

Keywords:  Autonomic nervous system; Central nervous system; Chronic nausea; Pathogenesis; Therapeutics

Year:  2016        PMID: 27734216     DOI: 10.1007/s11938-016-0107-x

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  50 in total

1.  The effect of intravenous vasopressin on gastric myoelectrical activity in human subjects.

Authors:  S D Caras; I Soykan; V Beverly; Z Lin; R W McCallum
Journal:  Neurogastroenterol Motil       Date:  1997-09       Impact factor: 3.598

2.  Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study.

Authors:  Nicholas J Talley; G Richard Locke; Yuri A Saito; Ann E Almazar; Ernest P Bouras; Colin W Howden; Brian E Lacy; John K DiBaise; Charlene M Prather; Bincy P Abraham; Hashem B El-Serag; Paul Moayyedi; Linda M Herrick; Lawrence A Szarka; Michael Camilleri; Frank A Hamilton; Cathy D Schleck; Katherine E Tilkes; Alan R Zinsmeister
Journal:  Gastroenterology       Date:  2015-04-25       Impact factor: 22.682

3.  The neuropharmacology of emesis: the role of receptors in neuromodulation of nausea and vomiting.

Authors:  R A Leslie; Y Shah; M Thejomayen; K M Murphy; H A Robertson
Journal:  Can J Physiol Pharmacol       Date:  1990-02       Impact factor: 2.273

4.  Brain Circuitry Supporting Multi-Organ Autonomic Outflow in Response to Nausea.

Authors:  Roberta Sclocco; Jieun Kim; Ronald G Garcia; James D Sheehan; Florian Beissner; Anna M Bianchi; Sergio Cerutti; Braden Kuo; Riccardo Barbieri; Vitaly Napadow
Journal:  Cereb Cortex       Date:  2014-08-12       Impact factor: 5.357

5.  A randomized, placebo-controlled, crossover, double-blind trial of the NK1 receptor antagonist aprepitant on gastrointestinal motor function in healthy humans.

Authors:  J L Madsen; S Fuglsang
Journal:  Aliment Pharmacol Ther       Date:  2008-01-16       Impact factor: 8.171

6.  The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.

Authors:  Rudolph M Navari; Cindy K Nagy; Sarah E Gray
Journal:  Support Care Cancer       Date:  2013-01-12       Impact factor: 3.603

Review 7.  Efficacy and safety of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) as reported in phase I and II studies: a systematic review.

Authors:  Ronald Chow; Leonard Chiu; Rudolph Navari; Steven Passik; Nicholas Chiu; Marko Popovic; Henry Lam; Mark Pasetka; Edward Chow; Carlo DeAngelis
Journal:  Support Care Cancer       Date:  2015-11-04       Impact factor: 3.603

8.  The psychophysiology of nausea.

Authors:  R M Stern
Journal:  Acta Biol Hung       Date:  2002

Review 9.  Neuroplasticity underlying the comorbidity of pain and depression.

Authors:  Lisa Doan; Toby Manders; Jing Wang
Journal:  Neural Plast       Date:  2015-02-25       Impact factor: 3.599

10.  Anti-emetic and emetic effects of erythromycin in Suncus murinus: role of vagal nerve activation, gastric motility stimulation and motilin receptors.

Authors:  Farideh A Javid; David C Bulmer; John Broad; Qasim Aziz; George E Dukes; Gareth J Sanger
Journal:  Eur J Pharmacol       Date:  2012-11-28       Impact factor: 4.432

View more
  4 in total

1.  Rare case of alimentary butylbiphenyl intoxication.

Authors:  Damian Simcik; Viktor Vorisek; Martin Jakl
Journal:  J Appl Biomed       Date:  2022-06-10       Impact factor: 0.500

2.  Mechanism and risk factors of nausea and vomiting after TACE: a retrospective analysis.

Authors:  Haohao Lu; Chuansheng Zheng; Bin Liang; Bin Xiong
Journal:  BMC Cancer       Date:  2021-05-07       Impact factor: 4.430

Review 3.  Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems.

Authors:  Weixia Zhong; Omar Shahbaz; Garrett Teskey; Abrianna Beever; Nala Kachour; Vishwanath Venketaraman; Nissar A Darmani
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

4.  Use of propofol for prevention of post-delivery nausea during cesarean section: a double-blind, randomized, placebo-controlled trial.

Authors:  Kun Niu; Hui Liu; Ruo-Wen Chen; Qi-Wu Fang; Hui Wen; Su-Mei Guo; John P Williams; Jian-Xiong An
Journal:  J Anesth       Date:  2018-09-12       Impact factor: 2.078

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.